Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Study Finds FDA Action on Unapproved Drugs Led to Higher Prices, Longer Shortages
Study Finds FDA Action on Unapproved Drugs Led to Higher Prices, Longer Shortages
Study Finds FDA Action on Unapproved Drugs Led to Higher Prices, Longer Shortages
Submitted by
admin
on September 28, 2017 - 11:12am
Source:
RAPS.org
News Tags:
FDA
drug approvals
drug pricing
Headline:
Study Finds FDA Action on Unapproved Drugs Led to Higher Prices, Longer Shortages
Do Not Allow Advertisers to Use My Personal information